Laboratorio Reig Jofre S.A. Logo

Laboratorio Reig Jofre S.A.

A pharmaceutical company making essential health products accessible in over 70 countries.

RJF | MC

Overview

Corporate Details

ISIN(s):
ES0165359029
LEI:
9598003MRMJHA81QJF20
Country:
Spain
Address:
Gran Capità 10, 08970 Sant Joan Despí
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Laboratorio Reig Jofre S.A., established in 1929, is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceutical products, food supplements, and nutritional cosmetics. The company operates four development and production centers in Europe, supporting its global distribution network which spans over 70 countries through subsidiaries and business partners. With a focus on technological specialization, Reig Jofre is dedicated to making essential health products accessible worldwide. The company employs over 1,100 people to support its international operations.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-14 11:36
Notice of Dividend Amount
Reig Jofre informa sobre el inicio del Scrip Dividend
Spanish 168.7 KB
2025-05-09 07:59
Share Issue/Capital Change
Reig Jofre remite las condiciones y el informe del Scrip Dividend
Spanish 454.9 KB
2025-05-09 07:48
Board/Management Information
Reig Jofre informa del cambio de Secretario no Consejero del Consejo de Adminis…
Spanish 150.2 KB
2025-05-09 07:44
Quarterly Report
Reig Jofre remite nota de prensa sobre los resultados del primer trimestre de 2…
Spanish 528.9 KB
2025-05-09 07:43
Investor Presentation
Reig Jofre presenta los resultados del primer trimestre de 2025
Spanish 4.6 MB
2025-05-08 19:43
Capital/Financing Update
Reig Jofre remite nota de prensa sobre la subvención obtenida del CDTi para imp…
Spanish 476.0 KB
2025-04-09 18:17
Post-Annual General Meeting Information
Reig Jofre remite los acuerdos adoptados en la Junta General de Accionistas de …
Spanish 160.4 KB
2025-04-04 01:28
Transaction in Own Shares
Reig Jofre informa de las operaciones realizadas durante el primer trimestre de…
English 705.9 KB
2025-03-07 09:54
Pre-Annual General Meeting Information
Convocatoria de la Junta General Ordinaria de Accionistas de 2025
Spanish 306.9 KB
2025-03-07 09:54
Pre-Annual General Meeting Information
Convocatoria de la Junta General Ordinaria de Accionistas de 2025
Spanish 306.9 KB
2025-03-07 00:00
Pre-Annual General Meeting Information
Convocatoria de la Junta General Ordinaria de Accionistas de 2025
Spanish 306.9 KB
2025-02-28 14:18
Remuneration Information
La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del …
Spanish 177.5 KB
2025-02-28 14:15
Governance Information
La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2024
Spanish 386.7 KB
2025-02-28 07:33
Earnings Release
Reig Jofre remite nota de prensa sobre los resultados de 2024
Spanish 867.1 KB
2025-02-28 07:31
Investor Presentation
Reig Jofre presenta los resultados de 2024
Spanish 1.9 MB

Automate Your Workflow. Get a real-time feed of all Laboratorio Reig Jofre S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Laboratorio Reig Jofre S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Laboratorio Reig Jofre S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
bioMérieux Logo
Provides in vitro diagnostic solutions for clinical and industrial microbiology.
France BIM
BioPorto Logo
IVD company developing NGAL biomarkers for early acute kidney injury (AKI) risk assessment.
Denmark BIOPOR
Biosergen AB Logo
Developing novel antifungal drugs for life-threatening infections in immunocompromised patients.
Sweden BIOSGN
Bio Solution Co.,Ltd. Logo
Develops cell therapies for degenerative diseases and supplies bio-lab reagents for R&D.
South Korea 086820
Biosynex Logo
European manufacturer of rapid diagnostic tests for professionals and consumer self-tests.
France ALBIO
Biotest AG Logo
Develops plasma protein products & biotherapeutics for immunology, haematology & intensive care.
Germany BIO3
Biotika A.S. Logo
Biotech firm making penicillin & polymyxin B APIs for human/vet use, plus contract manufacturing.
Slovakia BSL
Bioton S.A. Logo
Develops and manufactures recombinant human insulin for global diabetes care solutions.
Poland BIO
BIOVENTIX PLC Logo
Develops high-affinity sheep monoclonal antibodies for global clinical diagnostic immunoassays.
United Kingdom BVXP
Bioversys N Logo
Develops novel therapeutics to combat antimicrobial resistance in life-threatening infections.
Switzerland BIOV

Talk to a Data Expert

Have a question? We'll get back to you promptly.